ACTU
Actuate Therapeutics Inc. (ACTU)
Market Closed
9 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
7. 45
-0.04
-0.53%
$
166.65M Market Cap
- P/E Ratio
0% Div Yield
53,383 Volume
- Eps
$ 7.49
Previous Close Day Range
7.28 7.62
Year Range
5.47 11.99
Want to track ACTU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ACTU ACTU Actuate Therapeutics Inc. 3 Dec 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 13 Nov 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 12 Nov 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 23 Sep 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 3 Sep 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 14 Aug 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 22 Jul 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 28 May 2025 | | - | - |
| ACTU ACTU Actuate Therapeutics Inc. 27 Nov 2024 | | - | - |
ACTU Earnings Reports FAQ
What is the earnings per share (EPS) for ACTU?
EPS data for ACTU is currently not available, as Actuate Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Actuate Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Actuate Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Actuate Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ACTU at this time, as Actuate Therapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
